Daewoong Pharmaceutical about to launch first domestic generic in the U.S.

‘Daewoong Meropenem Inj’ will first enter the U.S. as a Korean generic product.

On the 5^th, Daewoong Pharmaceutical(CEO Jong-ok Lee) announced ‘Daewoong Meropenem Inj,’ a carbapenem-type antibiotic, has acquired approval from the US Food and Drug Administration(FDA).

The approval was finalized after the company established a branch in Maryland in 2009 and applied for the Abbreviated New Drug ...